Evidence map›Paper›PMID 30893808›Full record

ArticleMolecules (Basel, Switzerland)2019

Derivatization of Rosmarinic Acid Enhances its in vitro Antitumor, Antimicrobial and Antiprotozoal Properties.

Silvia Bittner Fialová, Martin Kello, Matúš Čoma, Lívia Slobodníková, Eva Drobná, Ivana Holková, Mária Garajová, Martin Mrva, Vlastimil Zachar, Miloš Lukáč

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 49 citations in OpenAlex.

  1. Efficacy of phosphonium amphiphilic salts against Acanthamoeba genotype T4.International journal for parasitology. Drugs and drug resistance · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The chemoprotective hormetic effects of rosmarinic acid.Open medicine (Warsaw, Poland) · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Antimicrobial and Antioxidant Properties of FourMolecules (Basel, Switzerland) · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Silvia Bittner FialováDepartment of Pharmacognosy and Botany, Faculty of Pharmacy, Comenius University in Bratislava, Odbojárov 10, 832 32 Bratislava, Slovakia. fialova@fpharm.uniba.sk.
Martin KelloDepartment of Pharmacology, Faculty of Medicine, P. J. Šafárik University, Trieda SNP 1, 040 11 Košice, Slovakia. kellomartin@yahoo.com.ORCID 0000-0002-2454-5799
Matúš ČomaDepartment of Pharmacology, Faculty of Medicine, P. J. Šafárik University, Trieda SNP 1, 040 11 Košice, Slovakia. coma.matus@gmail.com.
Lívia SlobodníkováInstitute of Microbiology, Faculty of Medicine, Comenius University in Bratislava, Sasinkova 4, 811 08 Bratislava, Slovakia. livia.slobodnikova@fmed.uniba.sk.
Eva DrobnáDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Kalinčiakov 8, 832 32 Bratislava, Slovakia. drobna@fpharm.uniba.sk.
Ivana HolkováDepartment of Cell and Molecular Biology of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Kalinčiakov 8, 832 32 Bratislava, Slovakia. holkova@fpharm.uniba.sk.
Mária GarajováDepartment of Zoology, Faculty of Natural Sciences, Comenius University in Bratislava, Mlynská dolina Ilkovičova 6, 842 15 Bratislava, Slovakia. martin.mrva@uniba.sk.
Martin MrvaDepartment of Zoology, Faculty of Natural Sciences, Comenius University in Bratislava, Mlynská dolina Ilkovičova 6, 842 15 Bratislava, Slovakia. maria.garajova@uniba.sk.
Vlastimil ZacharDepartment of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Kalinčiakov 8, 832 32 Bratislava, Slovakia. vlastimil.zachar@gmail.com.
Miloš LukáčDepartment of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, Kalinčiakov 8, 832 32 Bratislava, Slovakia. lukac@fpharm.uniba.sk.
Comenius University Bratislava · SKUniversity of Pavol Jozef Šafárik · SK

Funding

Agentúra na Podporu Výskumu a Vývoja APVV-15-0123Agentúra na Podporu Výskumu a Vývoja APVV-16-0446CEBV ITMS: 26240120034Kultúrna a Edukacná Grantová Agentúra MŠVVaŠ SR KEGA 039UK-4/2019Operational Programme Research & Innovation ITMS2014 + 313011D103Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA-1/0290/16Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA-1/0298/16Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 1/0365/16Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA 1/0389/19Vedecká Grantová Agentúra MŠVVaŠ SR a SAV VEGA-1/0653/19
6 · The paper itself

Abstract

On its own, rosmarinic acid possesses multiple biological activities such as anti-inflammatory, antimicrobial, cardioprotective and antitumor properties, and these are the consequence of its ROS scavenging and inhibitory effect on inflammation. In this study, two quaternary phosphonium salts of rosmarinic acid were prepared for the purpose of increasing its penetration into biological systems with the aim of improving its antimicrobial, antifungal, antiprotozoal and antitumor activity. The synthetized molecules, the triphenylphosphonium and tricyclohexylphosphonium salts of rosmarinic acid, exhibited significantly stronger inhibitory effects on the growth of HCT116 cells with IC

Indexed as

AcanthamoebaAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAntiprotozoal AgentsCinnamatesDepsidesHCT116 CellsHumansMicrobial Sensitivity TestsOrganophosphorus CompoundsRosmarinic AcidAnti-Bacterial AgentsAntifungal AgentsAnti-Infective AgentsAntiprotozoal AgentsCinnamatesDepsidesOrganophosphorus CompoundsRosmarinic Acidanti-Acanthamoeba activityantibacterialanticancerantifungalMRSAquaternary phosphonium saltsrosmarinic acid

Identifiers

PMID30893808
PMCPMC6470549
OpenAlexW2922659951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.